SVRA
NASDAQ · Biotechnology
Savara Inc
$4.82
-0.13 (-2.63%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,205.8% upside
Low Target
$52.50
Average Target
$62.94
High Target
$80.97
Current Price
$4.82
Current
$4.82
$4.82
Target
$62.94
$62.94
$52.50
$62.94 avg
$80.97
Scenario Analysis
Bear Case
$52.50
989.2%
Low target
Base Case
$62.94
+1,205.8%
Avg target
Bull Case
$80.97
+1,579.9%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$7.01
-31.2% from high
52-Week Low
$3.86
+24.9% from low
Target vs 52W High
$62.94
+798.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |